Subscribe

What are you looking for?

Main Menu

明報新聞網

康方生物曾升逾13% 合作伙伴獲阿斯利康20億美元戰略股權投資

Future Wealths
Future Wealths
29 9 月, 2026
One Min Read
1 Views
0 Comments
康方生物(9926)曾升近13.5%，創三個月來最大漲幅。彭博報道，此前該公司宣布其海外合作伙伴Summit Therapeutics已獲得阿斯利康20億美元的戰略股權投資，共同推進依沃西與AZ系列腫瘤產品聯合療法全球開發。

原文: https://finance.mingpao.com/fin/instantf/20260929/1790648382309/%E5%BA%B7%E6%96%B9%E7%94%9F%E7%89%A9%E6%9B%BE%E5%8D%87%E9%80%BE13-%E5%90%88%E4%BD%9C%E4%BC%99%E4%BC%B4%E7%8D%B2%E9%98%BF%E6%96%AF%E5%88%A9%E5%BA%B720%E5%84%84%E7%BE%8E%E5%85%83%E6%88%B0%E7%95%A5%E8%82%A1%E6%AC%8A%E6%8A%95%E8%B3%87%22%20target=%22blank

Last Update: 29 9 月, 2026

Please share this article if you like it!

Link Copied!
Future Wealths
Written By

Future Wealths

Other Articles

Related Posts

Our site uses cookies. By using this site, you agree to the Privacy Policy and Terms of Use.

Accept